Inflammation and dephosphorylation of the tight junction protein occludin in an experimental model of multiple sclerosis

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961

The rat brain in stereotaxic coordinates

Palkovits, M. (1983) · Neuropeptides · doi:10.1016/0143-4179(83)90049-5 · Cited by 28,959

The Rat Brain in Stereotaxic Coordinates

Paxinos, G., & Watson, C. (1983) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 28,585

Mass Spectrometric Sequencing of Proteins from Silver-Stained Polyacrylamide Gels

Shevchenko, A., Wilm, M. S., Vorm, O., & Mann, M. (1996) · Analytical Chemistry · doi:10.1021/ac950914h · Cited by 8,996

Probability-based protein identification by searching sequence databases using mass spectrometry data

Perkins, D. N., Pappin, D., Creasy, D. M., & Cottrell, J. S. (1999) · Electrophoresis · doi:10.1002/(sici)1522-2683(19991201)20:18 · Cited by 8,264

An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database

Eng, J. K., McCormack, A. L., & Yates, J. R. (1994) · Journal of the American Society for Mass Spectrometry · doi:10.1016/1044-0305(94)80016-2 · Cited by 6,484

A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids.

Wessel, D., & Flügge, U. (1984) · Analytical Biochemistry · doi:10.1016/0003-2697(84)90782-6 · Cited by 3,997

Size-selective loosening of the blood-brain barrier in claudin-5–deficient mice

Nitta, T., Hata, M., Gotoh, S., Seo, Y., Sasaki, H., Hashimoto, N., Furuse, M., & Tsukita, S. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200302070 · Cited by 1,917

Multiple sclerosis

Compston, A., & Coles, A. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08220-x · Cited by 1,743

Regulation of JAK–STAT signalling in the immune system

Shuai, K., & Liu, B. (2003) · Nature reviews. Immunology · doi:10.1038/nri1226 · Cited by 1,410

The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders

Zlokovic, B. V. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.003 · Cited by 3,280

Zonulin and Its Regulation of Intestinal Barrier Function: The Biological Door to Inflammation, Autoimmunity, and Cancer

Fasano, A. (2011) · Physiological Reviews · doi:10.1152/physrev.00003.2008 · Cited by 1,063

The Blood-Brain Barrier in Brain Homeostasis and Neurological Diseases

Weiss, N., Miller, F., Cazaubon, S., & Couraud, P.-O. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.10.022 · Cited by 731

VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown

Argaw, A. T., Gurfein, B. T., Zhang, Y., Zameer, A., & John, G. R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808698106 · Cited by 666

Tight junctions at the blood brain barrier: physiological architecture and disease-associated dysregulation

Luissint, A.-C., Artus, C., Glacial, F., Ganeshamoorthy, K., & Couraud, P.-O. (2012) · Fluids and Barriers of the CNS · doi:10.1186/2045-8118-9-23 · Cited by 654

Engaging neuroscience to advance translational research in brain barrier biology

Neuwelt, E. A., Bauer, B., Fahlke, C. M., Fricker, G., Iadecola, C., Janigro, D., Leybaert, L., Molnár, Z., O’Donnell, M. E., Povlishock, J. T., et al. (2011) · Nature reviews. Neuroscience · doi:10.1038/nrn2995 · Cited by 594

Brain Endothelial Cell-Cell Junctions: How to “Open” the Blood Brain Barrier

Stamatovic, S. M., Keep, R. F., & Andjelkovic, A. V. (2008) · Current Neuropharmacology · doi:10.2174/157015908785777210 · Cited by 541

Involvement of ROS in BBB dysfunction

Pun, P. B. L., Lu, J., & Moochhala, S. (2009) · Free Radical Research · doi:10.1080/10715760902751902 · Cited by 469

Brain endothelial cells and the glio-vascular complex

Wolburg, H., Noell, S., Mack, A., Wolburg-Buchholz, K., & Fallier-Becker, P. (2009) · Cell and Tissue Research · doi:10.1007/s00441-008-0658-9 · Cited by 438

Age-associated Physiological and Pathological Changes at the Blood-Brain Barrier: A Review

Erdő, F., Denes, L., & de Lange, E. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16679420 · Cited by 426

Occludin: One Protein, Many Forms

Cummins, P. M. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.06029-11 · Cited by 409

Endothelial tight junctions and their regulatory signaling pathways in vascular homeostasis and disease

Cong, X., & Kong, W. (2019) · Cellular Signalling · doi:10.1016/j.cellsig.2019.109485 · Cited by 312

Viral Infection of the Central Nervous System and Neuroinflammation Precede Blood-Brain Barrier Disruption during Japanese Encephalitis Virus Infection

Li, F., Wang, Y., Lan, Y., Cao, S., Wang, K., Yuan, J., Wang, C., Wang, K., Cui, M., & Fu, Z. F. (2015) · Journal of Virology · doi:10.1128/jvi.00143-15 · Cited by 277

Blood–brain barrier disruption and enhanced vascular permeability in the multiple sclerosis model EAE

Bennett, J. L., Basivireddy, J., Kollar, A., Biron, K. E., Reickmann, P., Jefferies, W. A., & McQuaid, S. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.08.011 · Cited by 271

Review: Role of developmental inflammation and blood–brain barrier dysfunction in neurodevelopmental and neurodegenerative diseases

Stolp, H. B., & Dzięgielewska, K. M. (2008) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2008.01005.x · Cited by 263

Tight junction modulation of the blood brain barrier: CNS delivery of small molecules

Greene, C., & Campbell, M. (2016) · Tissue Barriers · doi:10.1080/21688370.2015.1138017 · Cited by 254

Review: Leucocyte–endothelial cell crosstalk at the blood–brain barrier: A prerequisite for successful immune cell entry to the brain

Greenwood, J., Heasman, S. J., Alvarez, J. I., Prat, A., Lyck, R., & Engelhardt, B. (2011) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2010.01140.x · Cited by 240

Therapeutic Benefits from Nanoparticles: The Potential Significance of Nanoscience in Diseases with Compromise to the Blood Brain Barrier

Krol, S., Macrez, R., Docagne, F., Defer, G. L., Laurent, S., Rahman, M., Hajipour, M. J., Kehoe, P. G., & Mahmoudi, M. (2012) · Chemical Reviews · doi:10.1021/cr200472g · Cited by 219

Friends or foes: matrix metalloproteinases and their multifaceted roles in neurodegenerative diseases

Brkic, M., Balusu, S., Libert, C., & Vandenbroucke, R. E. (2015) · Mediators of Inflammation · doi:10.1155/2015/620581 · Cited by 205

Oxidative Stress-Mediated Blood-Brain Barrier (BBB) Disruption in Neurological Diseases

Song, K., Li, Y., Zhang, H., An, N., Wei, Y., Wang, L., Tian, C., Yuan, M., Sun, Y., Xing, Y., et al. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/4356386 · Cited by 208

Multifaceted Role of Matrix Metalloproteinases in Neurodegenerative Diseases: Pathophysiological and Therapeutic Perspectives

Behl, T., Kaur, G., Sehgal, A., Bhardwaj, S., Singh, S., Buhaș, C. L., Pusta, C. T. J., Uivaroșan, D., Munteanu, M. A., & BUNGAU, S. G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031413 · Cited by 198

Tight Junctions in Brain Barriers During Central Nervous System Inflammation

Coisne, C., & Engelhardt, B. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.3929 · Cited by 191

Brain Barrier Breakdown as a Cause and Consequence of Neuroinflammation in Sepsis

Danielski, L. G., Giustina, A. D., Badawy, M., Barichello, T., Quevedo, J., Dal-Pizzol, F., & Petronilho, F. (2018) · Molecular Neurobiology · doi:10.1007/s12035-016-0356-7 · Cited by 182

A Critical Review and Meta-Analysis of Impacts of Per- and Polyfluorinated Substances on the Brain and Behavior

Starnes, H. M., Rock, K. D., Jackson, T. W., & Belcher, S. M. (2022) · Frontiers in Toxicology · doi:10.3389/ftox.2022.881584 · Cited by 166

Claudin-1 induced sealing of blood–brain barrier tight junctions ameliorates chronic experimental autoimmune encephalomyelitis

Pfeiffer, F., Schäfer, J., Lyck, R., Makrides, V., Brunner, S., Schaeren-Wiemers, N., Deutsch, U., & Engelhardt, B. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0883-2 · Cited by 160

Breakdown of the Blood-Brain Barrier during Tick-Borne Encephalitis in Mice Is Not Dependent on CD8+ T-Cells

Růžek, D., Salát, J., Singh, S. K., & Kopecký, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020472 · Cited by 159

MMP9 modulates tight junction integrity and cell viability in human airway epithelia

Vermeer, P. D., Denker, J., Estin, M. L., Moninger, T. O., Keshavjee, S. H., Karp, P. H., Kline, J. N., & Zabner, J. (2009) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.90578.2008 · Cited by 151

Sulforaphane ameliorates the development of experimental autoimmune encephalomyelitis by antagonizing oxidative stress and Th17-related inflammation in mice

Li, B., Cui, W., Liu, J., Li, R., Liu, Q., Xie, X.-H., Ge, X., Zhang, J., Song, X., Wang, Y., et al. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.10.002 · Cited by 138

Endothelial cell junctions and the regulation of vascular permeability and leukocyte transmigration

Aghajanian, A., Wittchen, E. S., Allingham, M. J., Garrett, T. A., & Burridge, K. (2008) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.03087.x · Cited by 122

PPARs in the central nervous system: roles in neurodegeneration and neuroinflammation

Zolezzi, J. M., Santos, M. J., Candia, S. B., Pinto, C., Godoy, J. A., & Inestrosa, N. C. (2017) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.12320 · Cited by 123

Occludin regulation of blood–brain barrier and potential therapeutic target in ischemic stroke

Qi, Z., Yuan, S., & Liu, K. (2020) · Brain Circulation · doi:10.4103/bc.bc_29_20 · Cited by 118

Basic physiology of the blood-brain barrier in health and disease: a brief overview

Kaya, M., & Ahıshalı, B. (2020) · Tissue Barriers · doi:10.1080/21688370.2020.1840913 · Cited by 126

Crosstalk between Neuron and Glial Cells in Oxidative Injury and Neuroprotection

Lee, K. H., Cha, M., & Lee, B. H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413315 · Cited by 104

Involvement of Claudin-11 in Disruption of Blood-Brain, -Spinal Cord, and -Arachnoid Barriers in Multiple Sclerosis

Uchida, Y., Sumiya, T., Tachikawa, M., Yamakawa, T., Murata, S., Yagi, Y., Sato, K., Stephan, A., Ito, K., Ohtsuki, S., et al. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1207-5 · Cited by 97

The role of the blood–brain barrier in the development and treatment of migraine and other pain disorders

DosSantos, M. F. H., Afonso, R. C. D. H., de Lima, R. L., DaSilva, A. F. M., & Moura‐Neto, V. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00302 · Cited by 94

The “Frail” Brain Blood Barrier in Neurodegenerative Diseases: Role of Early Disruption of Endothelial Cell-to-Cell Connections

Maiuolo, J., Gliozzi, M., Musolino, V., Scicchitano, M., Carresi, C., Scarano, F., Bosco, F., Nucera, S., Ruga, S., Zito, M. C., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092693 · Cited by 87

Blockade of the kinin receptor B1 protects from autoimmune CNS disease by reducing leukocyte trafficking

Göbel, K., Pankratz, S., Schneider‐Hohendorf, T., Bittner, S., Schuhmann, M. K., Langer, H. F., Stoll, G., Wiendl, H., Kleinschnitz, C., & Meuth, S. G. (2011) · Journal of Autoimmunity · doi:10.1016/j.jaut.2010.11.004 · Cited by 89

Novel 3D analysis of Claudin-5 reveals significant endothelial heterogeneity among CNS microvessels

Paul, D., Cowan, A. E., Ge, S., & Pachter, J. S. (2012) · Microvascular Research · doi:10.1016/j.mvr.2012.12.001 · Cited by 77

Blood-Brain Barrier Alterations in the Cerebral Cortex in Experimental Autoimmune Encephalomyelitis

Errede, M., Girolamo, F., Ferrara, G. B., Strippoli, M., Morando, S., Boldrin, V., Rizzi, M., Uccelli, A., Perris, R., Bendotti, C., et al. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31826ac110 · Cited by 75

Age-dependent changes at the blood-brain barrier. A Comparative structural and functional study in young adult and middle aged rats

Bors, L. A., Tóth, K., Tóth, E. Z., Bajza, Á., Csorba, A., Szigeti, K., Máthé, D., Perlaki, G., Orsi, G., Tóth, G. K., et al. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.03.001 · Cited by 81

Mouse Adenovirus Type 1-Induced Breakdown of the Blood-Brain Barrier

Gralinski, L. E., Ashley, S. L., Dixon, S. D., & Spindler, K. R. (2009) · Journal of Virology · doi:10.1128/jvi.00954-09 · Cited by 70

For the assessment of intestinal permeability, size matters.

Vojdani, A. (2013) · PubMed · Cited by 69

Tight junction proteins expression and modulation in immune cells and multiple sclerosis

Mandel, I., Paperna, T., Glass‐Marmor, L., Volkowich, A., Badarny, S., Schwartz, I., Vardi, P., Koren, I., & Miller, A. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01380.x · Cited by 63

Myelin basic protein induces inflammatory mediators from primary human endothelial cells and blood–brain barrier disruption: implications for the pathogenesis of multiple sclerosis

D’Aversa, T. G., Eugenín, E. A., Lopez, L., & Berman, J. W. (2012) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2012.01279.x · Cited by 64

Astrocytes in multiple sclerosis and experimental autoimmune encephalomyelitis: Star-shaped cells illuminating the darkness of CNS autoimmunity

Yi, W., Schlüter, D., & Wang, X. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.05.029 · Cited by 67

Nanotechnologies: A Strategy to Overcome Blood-Brain Barrier

Rosa, G. D., Salzano, G., Caraglia, M., & Abbruzzese, A. (2011) · Current Drug Metabolism · doi:10.2174/138920012798356943 · Cited by 62

Tight junctions in neurological diseases

Bednarczyk, J., & Łukasiuk, K. (2011) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2011-1861 · Cited by 64

Profiling and Identification of Cerebrospinal Fluid Proteins in a Rat EAE Model of Multiple Sclerosis

Rosenling, T., Stoop, M. P., Attali, A., van Aken, H. H. M., Suidgeest, E., Christin, C., Stingl, C., Suits, F., Horvatovich, P. L., Hintzen, R. Q., et al. (2012) · Journal of Proteome Research · doi:10.1021/pr201244t · Cited by 57

Alzheimer’s disease: relevant molecular and physiopathological events affecting amyloid-β brain balance and the putative role of PPARs

Zolezzi, J. M., Candia, S. B., Santos, M. J., & Inestrosa, N. C. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00176 · Cited by 56

The Isolated Brain Microvessel: A Versatile Experimental Model of the Blood-Brain Barrier

Pardridge, W. M. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00398 · Cited by 52

Administration of an antagonist of P2X7 receptor to EAE rats prevents a decrease of expression of claudin-5 in cerebral capillaries

Grygorowicz, T., Dąbrowska‐Bouta, B., & Strużyńska, L. (2018) · Purinergic Signalling · doi:10.1007/s11302-018-9620-9 · Cited by 48

Dysfunction of the neurovascular unit in diabetes-related neurodegeneration

Yan, C., Zhou, Y., Chen, Q., Luo, Y., Zhang, J. H., Huang, H., & Shao, A. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110656 · Cited by 47

Hypoxia increases transepithelial electrical conductance and reduces occludin at the plasma membrane in alveolar epithelial cells via PKC-ζ and PP2A pathway

Caraballo, J. C., Yshii, C., Butti, M. L., Westphal, W., Borcherding, J. A., Allamargot, C., & Comellas, A. P. (2011) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00109.2010 · Cited by 44

Peroxisome Proliferator-activated Receptors and Alzheimer's Disease: Hitting the Blood–Brain Barrier

Zolezzi, J. M., & Inestrosa, N. C. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8435-5 · Cited by 46

Treatment with tanshinone IIA suppresses disruption of the blood-brain barrier and reduces expression of adhesion molecules and chemokines in experimental autoimmune encephalomyelitis

Yang, X., Yan, J., & Feng, J. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.12.014 · Cited by 43

Idazoxan reduces blood–brain barrier damage during experimental autoimmune encephalomyelitis in mouse

Wang, X., Fang, H.-L., Chen, Y., Liang, S.-S., Zhu, Z.-G., Zeng, Q., Li, J., Xu, H., Shao, B., He, J., et al. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.04.034 · Cited by 39

Autophagy-related gene16L2, a potential serum biomarker of multiple sclerosis evaluated by bead-based proteomic technology

Yin, L., Liu, J., Dong, H., Xu, E., Qiao, Y., Wang, L., Zhang, L., Jia, J., Li, L., & Geng, X. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2013.12.070 · Cited by 36

The blood brain barrier: Insights from development and ageing

Delaney, C. P., & Campbell, M. (2017) · Tissue Barriers · doi:10.1080/21688370.2017.1373897 · Cited by 36

Kv1.3 channel blocker (ImKTx88) maintains blood–brain barrier in experimental autoimmune encephalomyelitis

Huang, J., Han, S. H., Sun, Q., Zhao, Y., Liu, J., Yuan, X., Mao, W., Peng, B., Liu, W., Yin, J., et al. (2017) · Cell & Bioscience · doi:10.1186/s13578-017-0158-2 · Cited by 34

The effects of fasudil on the permeability of the rat blood–brain barrier and blood–spinal cord barrier following experimental autoimmune encephalomyelitis

Huang, X.-N., Fu, J. X., & Wang, W. Z. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.08.015 · Cited by 34

Primary tumor‐secreted VEGF induces vascular hyperpermeability in premetastatic lung via the occludin phosphorylation/ubiquitination pathway

Li, R., Qi, Y., Jiang, M., Zhang, T., Wang, H., Wang, L., & Han, M. (2019) · Molecular Carcinogenesis · doi:10.1002/mc.23120 · Cited by 31

Hippocampal transcriptional dysregulation after renal ischemia and reperfusion

Chou, A., Lee, C.-M., Chen, C., Liou, J.-T., Liu, F.-C., Chen, Y.-L., & Day, Y. (2014) · Brain Research · doi:10.1016/j.brainres.2014.07.030 · Cited by 31

Does VEGF secreted by leukemic cells increase the permeability of blood–brain barrier by disrupting tight-junction proteins in central nervous system leukemia?

Feng, S., Huang, Y., & Chen, Z. (2011) · Medical Hypotheses · doi:10.1016/j.mehy.2010.12.001 · Cited by 30

Altered expression of tight junction proteins and matrix metalloproteinases in thiamine-deficient mouse brain

Beauchesne, É., Desjardins, P., Hazell, A. S., & Butterworth, R. F. (2009) · Neurochemistry International · doi:10.1016/j.neuint.2009.03.014 · Cited by 29

Activation of Annexin A2 signaling at the blood–brain barrier in a mouse model of multiple sclerosis

Tezuka, K., Suzuki, M., Sato, R., Kawarada, S., Terasaki, T., & Uchida, Y. (2022) · Journal of Neurochemistry · doi:10.1111/jnc.15578 · Cited by 30

An oxygen-adaptive interaction between SNHG12 and occludin maintains blood-brain barrier integrity

Li, Y., Wei, J., Liu, H., Wang, K.-J., Jin, S.-N., Su, Z.-K., Wang, H., Shi, J.-X., Li, B., Shang, D., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110656 · Cited by 27

Enlargement of Cerebral Ventricles as an Early Indicator of Encephalomyelitis

Lepore, S., Waiczies, H., Hentschel, J., Ji, Y., Skodowski, J., Pohlmann, A., Millward, J. M., Paul, F., Wuerfel, J. T., Niendorf, T., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072841 · Cited by 29

Effects of Peripheral Inflammation on the Blood-Spinal Cord Barrier

Xanthos, D. N., Püngel, I., Wunderbaldinger, G., & Sandkühler, J. (2012) · Molecular Pain · doi:10.1186/1744-8069-8-44 · Cited by 28

Effects of prednisolone on the dystrophin-associated proteins in the blood–brain barrier and skeletal muscle of dystrophic mdx mice

Tamma, R., Annese, T., Capogrosso, R. F., Cozzoli, A., Benagiano, V., Sblendorio, V. T., Ruggieri, S., Enrico Crivellato, B., Specchia, G., Ribatti, D., et al. (2013) · Laboratory Investigation · doi:10.1038/labinvest.2013.46 · Cited by 28

Intestinal Dysbiosis, Tight Junction Proteins, and Inflammation in Rheumatoid Arthritis Patients: A Cross-Sectional Study

Mucientes, A., Lisbona-Montañez, J. M., Vázquez, N. M., Ruiz‐Limón, P., Arija, S. M., García-Studer, A., Ortiz-Marquez, F., & Fernández‐Nebro, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168649 · Cited by 29

Altered occludin expression in brain capillaries induced by obstructive jaundice in rats

Faropoulos, K., Chroni, E., Assimakopoulos, S. F., Mavrakis, A. G., Stamatopoulou, V., Toumpeki, C., Drainas, D., Grintzalis, K., Papapostolou, I., Georgiou, C. D., et al. (2010) · Brain Research · doi:10.1016/j.brainres.2010.02.020 · Cited by 26

Lymphocyte transmigration in the brain: a new way of thinking

Lee, B. P.-L., & Imhof, B. A. (2008) · Nature Immunology · doi:10.1038/ni0208-117 · Cited by 26

Effects of fumaric acid esters on blood–brain barrier tight junction proteins

Bénardais, K., Pul, R., Singh, V., Skripuletz, T., Lee, D.-H., Linker, R. A., Gudi, V., & Stangel, M. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.09.038 · Cited by 24

Matrine treatment induced an A2 astrocyte phenotype and protected the blood-brain barrier in CNS autoimmunity

Jing, Y., Ma, R., Chu, Y., Dou, M., Wang, M., Li, X., & Zhu, L. D. (2021) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2021.102004 · Cited by 24

Vascular damage in the central nervous system: a multifaceted role for vascular-derived TGF-β

Beck, K., & Schachtrup, K. (2011) · Cell and Tissue Research · doi:10.1007/s00441-011-1228-0 · Cited by 20

Effect of Systemic Infection Induced by Pseudomonas aeruginosa on the Brain Uptake of Colistin in Mice

Jin, L., Li, J., Nation, R. L., & Nicolazzo, J. A. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00713-12 · Cited by 19

Evaluation of the gut microbiome in association with biological signatures of inflammation in murine polytrauma and shock

Appiah, S. A., Foxx, C. L., Langgartner, D., Palmer, A., Zambrano, C. A., Braumüller, S. T., Schaefer, E. J., Wachter, U. A., Elam, B. L., Radermacher, P., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-85897-w · Cited by 18

ALS-causing SOD1 mutants regulate occludin phosphorylation/ubiquitination and endocytic trafficking via the ITCH/Eps15/Rab5 axis

Tang, J., Kang, Y., Zhou, Y., Li, X., Lan, J., Wu, L., Feng, X., & Peng, Y. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105315 · Cited by 16

Restoring brain barriers: an innovative approach for treating neurological disorders

Lemarchant, S., Engelhardt, B., Cicchetti, F., Bix, G. J., Janus, A., Godfrin, Y., Blasco, H., Campbell, M., & Jacquet, A. D. R. (2025) · Fluids and Barriers of the CNS · doi:10.1186/s12987-025-00688-z · Cited by 16

The Relationship Between Aquaporin‐4 Expression and Blood‐Brain and Spinal Cord Barrier Permeability Following Experimental Autoimmune Encephalomyelitis in the Rat

Huang, X.-N., Wang, W., Fu, J., & Wang, H. (2010) · The Anatomical Record · doi:10.1002/ar.21286 · Cited by 17

Discovery of Novel Disease-specific and Membrane-associated Candidate Markers in a Mouse Model of Multiple Sclerosis*

Dagley, L. F., Croft, N., Isserlin, R., Olsen, J. B., Fong, V., Emili, A., & Purcell, A. (2013) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.033340 · Cited by 12

Treating brain diseases using systemic parenterally-administered protein therapeutics: Dysfunction of the brain barriers and potential strategies

Zaghmi, A., Drouin‐Ouellet, J., Brambilla, D., & Gauthier, M. A. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120461 · Cited by 17

Vascular multiple sclerosis: addressing the pathogenesis, genetics, pro-angiogenic factors, and vascular abnormalities, along with the role of vascular intervention

Prajjwal, P., Shree, A., Das, S., Inban, P., Ghosh, S., Senthil, A., Gurav, J., Kundu, M., Marsool, M. D. M., Gadam, S., et al. (2023) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000001177 · Cited by 14

The experimental autoimmune encephalomyelitis model for proteomic biomarker studies: From rat to human

Rosenling, T., Attali, A., Luider, T. M., & Bischoff, R. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.02.004 · Cited by 14

Mild experimental autoimmune encephalitis as a tool to induce blood–brain barrier dysfunction

Boettger, M. K., Weishaupt, A., Geis, C., Toyka, K. V., & Sommer, C. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0342-6 · Cited by 13

The Use of Agmatine Provides the New Insight in an Experimental Model of Multiple Sclerosis

Ninković, M., Stevanović, I. D., Stojanović, I. R., Ljubisavljević, S., Bašić, J., & Perić, P. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1655-5 · Cited by 10

Diabetes-Related Alteration of Occludin Expression in Rat Blood–Spinal Cord Barrier

Zhao, Y., Liu, X., Ai-yong, Y., Zhou, Y., & Liu, B. (2010) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-010-9099-7 · Cited by 8

MSCs engineered with secreted Klotho alleviate blood–brain barrier disruption and reduce neuroinflammation more effectively than MSCs in experimental autoimmune encephalomyelitis

Maleki, N., Kalkhorann, M. R., Aleagha, M. S. E., Emami, A., & Allameh, A. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04428-w · Cited by 7

Mechanisms of Blood–Brain Barrier Disintegration in the Pathophysiology of Multiple Sclerosis

Stevenson, E. V., Alexander, J. S., Yun, J. W., Becker, F., Gonzalez‐Toledo, E., & Minagar, A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800763-1.00016-6 · Cited by 7

Implication de la barrière hématoencéphalique dans la physiopathologie des maladies neurologiques : Partie II

Weiss, N., Miller, F., Cazaubon, S. M., & Couraud, P. (2009) · Revue Neurologique · doi:10.1016/j.neurol.2009.04.013 · Cited by 6

Dual inhibition of canonical and noncanonical PAR‐1 by SCH79797 mitigates neurodegeneration in 3‐NP‐induced Huntington's disease: An in vivo and in silico approach

Abdel‐Latif, R. T., El-Abhar, H. S., Abdallah, D. M., Fawzy, I. M., & Mansour, S. M. (2025) · Archiv der Pharmazie · doi:10.1002/ardp.202400846 · Cited by 5

Deficiency in N-cadherin-Akt3 signaling impairs the blood-brain barrier

Lee, Q. S., Chan, W. C., Zhao, S., Hailemeskel, H. M., Thomas, R., Zafar, M., Mir, F., Tóth, P. T., Avanaki, K., Tai, L. M., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115831 · Cited by 5

Transition from identity to bioactivity‐guided proteomics for biomarker discovery with focus on the PF2D platform

Ménoret, A., Crocker, S. J., Rodríguez, A., Rathinam, V. A. K., Clark, R. B., & Vella, A. T. (2015) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201500029 · Cited by 4

Fundamentals of Brain–Barrier Anatomy and Global Functions

Greene, C., Campbell, M., & Janigro, D. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813997-4.00001-3 · Cited by 5

Modulating Role of TTR in Aβ Toxicity, from Health to Disease

Cardoso, I., Santos, L. M., & Alemi, M. (2016) · InTech eBooks · doi:10.5772/63194 · Cited by 7

Brain Edema in Neurological Diseases

Candelario‐Jalil, E., Taheri, S., & Rosenberg, G. A. (2010) · Advances in neurobiology · doi:10.1007/978-1-4419-7104-3_5 · Cited by 4

Cigarette smoke alters calcium flux to induce PP2A membrane trafficking and endothelial cell permeability

Dabo, A. J., Raghavan, S., Ezegbunam, W., Thankachen, J., Evgrafov, O. V., Majka, S., Geraghty, P. M., & Foronjy, R. (2024) · Scientific Reports · doi:10.1038/s41598-024-77776-x · Cited by 3

Disease Influence on BBB Transport in Neurodegenerative Disorders

de Lange, E. C. M. (2013) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-1-4614-9105-7_22 · Cited by 3

Decoding the regulatory network of microRNAs, lncRNAs, and transcription factors in relapsing-remitting multiple sclerosis: A case-control in silico study

Lui, M., D’Angiolini, S., Mazzon, E., & Calabrò, M. (2025) · Heliyon · doi:10.1016/j.heliyon.2025.e43854 · Cited by 2

Oligodendrocyte Metabolic Stress in Neurodegeneration

Radecki, D. Z., & Gow, A. (2013) · InTech eBooks · doi:10.5772/54461 · Cited by 2

Blood–brain barrier disruption and enhanced vascular permeability in the multiple sclerosis model EAE

Bennett, J. L., Basivireddy, J., Kollar, A., Biron, K. E., Reickmann, P., Jefferies, W. A., & McQuaid, S. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.08.011 · Cited by 271

Serum from patients with multiple sclerosis downregulates occludin and VE-cadherin expression in cultured endothelial cells

Minagar, A., Ostanin, D. V., Long, A. C., Jennings, M. H., Kelley, R. E., Sasaki, M., & Alexander, J. (2003) · Multiple Sclerosis Journal · doi:10.1191/1352458503ms916oa · Cited by 73

Activation of Annexin A2 signaling at the blood–brain barrier in a mouse model of multiple sclerosis

Tezuka, K., Suzuki, M., Sato, R., Kawarada, S., Terasaki, T., & Uchida, Y. (2022) · Journal of Neurochemistry · doi:10.1111/jnc.15578 · Cited by 30

Examination of Tight Junction Protein Expression and Distribution both in Enterocytes and Brain Capillary Endothelial Cells in an Experimental Model for Multiple sclerosis - A Link between Two Barriers

Goiricelaya, A. B. (2015)

Blocking PDGF-CC signaling ameliorates multiple sclerosis-like neuroinflammation by inhibiting disruption of the blood–brain barrier

Zeitelhofer, M., Adzemovic, M. Z., Moessinger, C., Stefanitsch, C., Strell, C., Muhl, L., Brundin, L., Fredriksson, L., Olsson, T. P., Eriksson, U., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-79598-z · Cited by 63